Jaffee Hannah, Eftekhari Sanaz, Carver Melanie
The Asthma and Allergy Foundation of America, 1235 S Clark St, Ste 305, Arlington, VA 22202 (
The Asthma and Allergy Foundation of America, Arlington, Virginia.
Prev Chronic Dis. 2024 Aug 8;21:E59. doi: 10.5888/pcd21.240058.
This study sought to identify COVID-19 and influenza vaccination rates and barriers among people with asthma. The Asthma and Allergy Foundation of America (AAFA) conducted an online survey from April to May in 2022 among a convenience sample of 350 individuals with asthma. Most survey respondents reported that they had received an influenza vaccine for the 2021-2022 flu season (77%) and at least 1 dose of a COVID-19 vaccine (87%). Age, gender, race and ethnicity, and household income were significantly associated with influenza vaccination. Age and urban-rural classification were associated with COVID-19 vaccination. Access issues were not commonly reported as vaccination barriers, highlighting educational opportunities.
本研究旨在确定哮喘患者中新冠病毒疾病(COVID-19)和流感疫苗的接种率及接种障碍。美国哮喘与过敏基金会(AAFA)于2022年4月至5月对350名哮喘患者的便利样本进行了一项在线调查。大多数调查受访者报告称,他们已接种2021 - 2022流感季的流感疫苗(77%)以及至少一剂新冠病毒疫苗(87%)。年龄、性别、种族和民族以及家庭收入与流感疫苗接种显著相关。年龄和城乡分类与新冠病毒疫苗接种相关。获得疫苗的问题通常未被报告为接种障碍,这凸显了教育机会。